Clavoton 1g - trihydrate 875 mg and clavulanic acid 125mg

Composition: in 1 tablet – Amoxicillin trihydrate 875 mg and clavulanic acid 125mg.

Pharmacotherapeutic group: Combinations of penicillins, including beta-lactamase inhibitors.

Indications: Clavoton is indicated for the treatment of the following infections:

Upper respiratory tract infections (as well ENT organ infections), including recurrent tonsillitis, acute bacterial sinusitis, otitis media)
Lower respiratory tract infections, including exacerbation of chronic bronchitis, lobar pneumonia and bronchopneumonia
Urinary tract infections, including cystitis, urethritis, pyelonephritis, infection of female genital organs, gonorrhea

Infections of skin and soft tissue, including cellulites
Bone and joint infections, including osteomyelitis
Odontogenic infection, including periodontitis, odontogenic maxillary sinusitis, severe dental abscess with spreading cellulitis
Other mixed infections (including septic abortion, puerperal sepsis, intra-abdominal sepsis) within the sequential therapy
Prevention of infections in surgical interventions
Animal bites
Infections caused by microorganisms susceptible to amoxicillin may be treated with the drug Clavoton as amoxicillin is one of its active ingredients.

Advantages:

Administration and dosage: According to doctors’ prescription.

Contraindications:

Hypersensitivity to the active substances, to any penicillin or to any other component of drug
History of a severe immediate hypersensitivity reaction (e.g. anaphylaxis) to another beta-lactam agent
History of jaundice/hepatic impairment due to amoxicillin/clavulanic acid

Use with precautions in case of:

Storage: Store at temperature not exceeding 25 ° C, in a dry place.

Packing: Blisters with 14 (2 x 7) f/c tablets in cardboard box along with a leaflet.

Produced by: "Medochemie", Cyprus

See also: http://www.medochemie.com/